Cargando…
Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
Membrane monocarboxylate transporter 1 (SLC16A1/MCT1) plays an important role in hepatocyte homeostasis, as well as drug handling. However, there is no available information about the impact of liver pathology on the transporter levels and function. The study was aimed to quantify SLC16A1 mRNA (qRT-...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084425/ https://www.ncbi.nlm.nih.gov/pubmed/32111097 http://dx.doi.org/10.3390/ijms21051606 |
_version_ | 1783508718745288704 |
---|---|
author | Droździk, Marek Szeląg-Pieniek, Sylwia Grzegółkowska, Justyna Łapczuk-Romańska, Joanna Post, Mariola Domagała, Pawel Miętkiewski, Janusz Oswald, Stefan Kurzawski, Mateusz |
author_facet | Droździk, Marek Szeląg-Pieniek, Sylwia Grzegółkowska, Justyna Łapczuk-Romańska, Joanna Post, Mariola Domagała, Pawel Miętkiewski, Janusz Oswald, Stefan Kurzawski, Mateusz |
author_sort | Droździk, Marek |
collection | PubMed |
description | Membrane monocarboxylate transporter 1 (SLC16A1/MCT1) plays an important role in hepatocyte homeostasis, as well as drug handling. However, there is no available information about the impact of liver pathology on the transporter levels and function. The study was aimed to quantify SLC16A1 mRNA (qRT-PCR) and MCT1 protein abundance (liquid chromatography–tandem mass spectrometry (LC¬¬–MS/MS)) in the livers of patients diagnosed, according to the standard clinical criteria, with hepatitis C, primary biliary cirrhosis, primary sclerosing hepatitis, alcoholic liver disease (ALD), and autoimmune hepatitis. The stage of liver dysfunction was classified according to Child–Pugh score. Downregulation of SLC16A1/MCT1 levels was observed in all liver pathology states, significantly for ALD. The progression of liver dysfunction, from Child–Pugh class A to C, involved the gradual decline in SLC16A1 mRNA and MCT1 protein abundance, reaching a clinically significant decrease in class C livers. Reduced levels of MCT1 were associated with significant intracellular lactate accumulation. The MCT1 transcript and protein did not demonstrate significant correlations regardless of the liver pathology analyzed, as well as the disease stage, suggesting posttranscriptional regulation, and several microRNAs were found as potential regulators of MCT1 abundance. MCT1 membrane immunolocalization without cytoplasmic retention was observed in all studied liver pathologies. Overall, the study demonstrates that SLC16A1/MCT1 is involved in liver pathology, especially in ALD. |
format | Online Article Text |
id | pubmed-7084425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70844252020-03-24 Monocarboxylate Transporter 1 (MCT1) in Liver Pathology Droździk, Marek Szeląg-Pieniek, Sylwia Grzegółkowska, Justyna Łapczuk-Romańska, Joanna Post, Mariola Domagała, Pawel Miętkiewski, Janusz Oswald, Stefan Kurzawski, Mateusz Int J Mol Sci Article Membrane monocarboxylate transporter 1 (SLC16A1/MCT1) plays an important role in hepatocyte homeostasis, as well as drug handling. However, there is no available information about the impact of liver pathology on the transporter levels and function. The study was aimed to quantify SLC16A1 mRNA (qRT-PCR) and MCT1 protein abundance (liquid chromatography–tandem mass spectrometry (LC¬¬–MS/MS)) in the livers of patients diagnosed, according to the standard clinical criteria, with hepatitis C, primary biliary cirrhosis, primary sclerosing hepatitis, alcoholic liver disease (ALD), and autoimmune hepatitis. The stage of liver dysfunction was classified according to Child–Pugh score. Downregulation of SLC16A1/MCT1 levels was observed in all liver pathology states, significantly for ALD. The progression of liver dysfunction, from Child–Pugh class A to C, involved the gradual decline in SLC16A1 mRNA and MCT1 protein abundance, reaching a clinically significant decrease in class C livers. Reduced levels of MCT1 were associated with significant intracellular lactate accumulation. The MCT1 transcript and protein did not demonstrate significant correlations regardless of the liver pathology analyzed, as well as the disease stage, suggesting posttranscriptional regulation, and several microRNAs were found as potential regulators of MCT1 abundance. MCT1 membrane immunolocalization without cytoplasmic retention was observed in all studied liver pathologies. Overall, the study demonstrates that SLC16A1/MCT1 is involved in liver pathology, especially in ALD. MDPI 2020-02-26 /pmc/articles/PMC7084425/ /pubmed/32111097 http://dx.doi.org/10.3390/ijms21051606 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Droździk, Marek Szeląg-Pieniek, Sylwia Grzegółkowska, Justyna Łapczuk-Romańska, Joanna Post, Mariola Domagała, Pawel Miętkiewski, Janusz Oswald, Stefan Kurzawski, Mateusz Monocarboxylate Transporter 1 (MCT1) in Liver Pathology |
title | Monocarboxylate Transporter 1 (MCT1) in Liver Pathology |
title_full | Monocarboxylate Transporter 1 (MCT1) in Liver Pathology |
title_fullStr | Monocarboxylate Transporter 1 (MCT1) in Liver Pathology |
title_full_unstemmed | Monocarboxylate Transporter 1 (MCT1) in Liver Pathology |
title_short | Monocarboxylate Transporter 1 (MCT1) in Liver Pathology |
title_sort | monocarboxylate transporter 1 (mct1) in liver pathology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084425/ https://www.ncbi.nlm.nih.gov/pubmed/32111097 http://dx.doi.org/10.3390/ijms21051606 |
work_keys_str_mv | AT drozdzikmarek monocarboxylatetransporter1mct1inliverpathology AT szelagpienieksylwia monocarboxylatetransporter1mct1inliverpathology AT grzegołkowskajustyna monocarboxylatetransporter1mct1inliverpathology AT łapczukromanskajoanna monocarboxylatetransporter1mct1inliverpathology AT postmariola monocarboxylatetransporter1mct1inliverpathology AT domagałapawel monocarboxylatetransporter1mct1inliverpathology AT mietkiewskijanusz monocarboxylatetransporter1mct1inliverpathology AT oswaldstefan monocarboxylatetransporter1mct1inliverpathology AT kurzawskimateusz monocarboxylatetransporter1mct1inliverpathology |